The announcement this morning that Tesco (LON:TSCO) is to change its chief executive should not immediately change investors' view of the stock, which remains a ‘sell’ according to Keith Bowman, equity analyst at Hargreaves Lansdown.
Latest from What Investment
Harry Nimmo’s Standard Life Investments UK Smaller Companies fund, long a beacon for smaller companies investors, has been named on Bestinvest’s 'Spot the Dog' list of underperforming funds.
Richard Buxton, manager of the £1.4 billion Old Mutual UK Alpha fund, has told What Investment that he intends to continue to add to his fund’s holdings in banking giant Barclays (LON:BARC), despite the negativity that surrounds the company at present.
High profile fund manager Neil Woodford, who raised £1.6 billion in just 13 days from investors in his new CF Woodford Equity Income fund, has bought shares in just two of the companies that have come to the market via initial public offerings (IPOs) this year.
Venture capital trusts (VCTs) are likely to hold particular attractions for investors searching for income over the coming year, according to Jason Hollands, managing director at Bestinvest.
Despite annual UK consumer price inflation (CPI) leaping to 1.9 per cent in June, compared to 1.5 per cent the previous month, investors should not be spooked into thinking that a rise in interest rates is now nearer at hand according to Ben Brettell, senior economist at Hargreaves Lansdown.
John Baker, the high performing manager of the JP Morgan Europe Dynamic Ex UK fund, has outlined the five stocks that he believes represent best value in the Eurozone at present.
Keith Wade, chief economist at Schroders, believes that while the case for investing in emerging markets is ‘compelling’, those looking at the asset class need to be very selective at present.
The M&G Recovery fund, which since 1969 has been a beacon for those seeking to invest in undervalued stocks in the UK, continues to shed cash as the fund continues to deeply underperform its sector.
Geoffrey Hsu, general partner at US-based Orbimed which manages the Biotech Growth investment trust (LON:BIOG), has said that the potential of biotech companies to launch multi-billion dollar drugs and grow their earnings is ‘much more substantial’ now than in previous years.
Further trading updates over time in line with the news released this morning from high-end clothing and luxury goods maker Burberry (LON:BRBY) are likely to put upward pressure on the share price, according to Richard Hunter, head of equities at Hargreaves Lansdown.
Andrew Goldberg, market strategist for Europe at JP Morgan Asset Management, believes that the economic recovery in the US and the UK is ‘far from secure’.
The policies of the major central banks mean that emerging markets are a more prudent investment right now, according to Jan Dehn, head of research at Ashmore.
Job Curtis: The UK stocks I'm buying for income, and those I've sold for the City of London investment trust
Job Curtis, long-serving manager of the £1.2 billion City of London investment trust (LON:CTY), has outlined the stocks he has been buying, and those he sold in the past month.
Star fund manager Neil Woodford has revealed the top ten stocks he has bought for his new CF Woodford Equity Income fund, which raised £1.6 billion in just 13 days when it launched in June.